44 results on '"Dowd, William N."'
Search Results
2. Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder
3. Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050--Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
4. Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
5. The Relationship Between Reductions in WHO Risk Drinking Levels During Treatment and Subsequent Healthcare Costs for the ACTIVE Workgroup
6. Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies
7. The impact of the abuse-deterrent reformulation of extended-release OxyContin on prescription pain reliever misuse and heroin initiation
8. Modeling the impact of a long‐term horizon and multiple treatment episodes on estimates of the cost‐effectiveness of alcohol treatment in the United States
9. Substance use disorder treatment admissions and state-level prenatal substance use policies: Evidence from a national treatment database
10. The effect of untargeted naloxone distribution on opioid overdose outcomes
11. Alcohol Consumption in Response to the COVID-19 Pandemic in the United States
12. Cost and Return on Investment of a Work–Family Intervention in the Extended Care Industry : Evidence From the Work, Family, and Health Network
13. Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health
14. An Exploratory Cost-Effectiveness Analysis of the Connected Health Intervention to Improve Care for People with Dementia: A Simulation Analysis
15. Tracking the Quality of Addiction Treatment Over Time and Across States: Using the Federal Government’s “Signs” of Higher Quality
16. Return on Investment of a Work–Family Intervention : Evidence From the Work, Family, and Health Network
17. Modeling the impact of COVID‐19 pandemic‐driven increases in alcohol consumption on health outcomes and hospitalization costs in the United States
18. Alcohol Consumption During the First Year of the COVID-19 Pandemic in the United States: Results From a Nationally Representative Longitudinal Survey
19. A time and motion study of Screening, Brief Intervention, and Referral to Treatment implementation in health‐care settings
20. Sustaining SBIRT in the wild: simulating revenues and costs for Screening, Brief Intervention and Referral to Treatment programs
21. Modeling the impact of COVID‐19 pandemic‐driven increases in alcohol consumption on health outcomes and hospitalization costs in the United States.
22. Alcohol Consumption During the First Year of the COVID-19 Pandemic in the United States: Results From a Nationally Representative Longitudinal Survey.
23. Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic
24. Development, Testing, and Dissemination of a Public-Facing Tool to Help Consumers Find Higher-Quality Addiction Treatment
25. Effect of increased alcohol consumption during COVID‐19 pandemic on alcohol‐associated liver disease: A modeling study
26. The Relationship Between Reductions in WHO Risk Drinking Levels During Treatment and Subsequent Healthcare Costs for the ACTIVE Workgroup
27. The Relationship Between End-of-Treatment Alcohol Use and Subsequent Healthcare Costs: Do Heavy Drinking Days Predict Higher Healthcare Costs?
28. SF‐6D utility scores for alcohol use disorder status and alcohol consumption risk levels in the US population
29. How Has Drinking Behavior Changed During the COVID-19 Pandemic?
30. Estimating Long-Term Drinking Patterns for People with Lifetime Alcohol Use Disorder
31. AppendixA4_online_supp – Supplemental material for Estimating Long-Term Drinking Patterns for People with Lifetime Alcohol Use Disorder
32. Alcohol Consumption in Response to the COVID-19 Pandemic in the United States.
33. SF‐6D utility scores for alcohol use disorder status and alcohol consumption risk levels in the US population.
34. Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder
35. An Exploratory Cost-Effectiveness Analysis of the Connected Health Intervention to Improve Care for People with Dementia: A Simulation Analysis
36. Sustaining SBIRT in the wild: simulating revenues and costs for Screening, Brief Intervention and Referral to Treatment programs
37. A time and motion study of Screening, Brief Intervention, and Referral to Treatment implementation in health-care settings
38. Behavioral Health Outcomes Among Adults: Associations With Individual and Community-Level Economic Conditions
39. Financial sustainability of screening, brief intervention, and referral to treatment programs in emergency department settings (part of Economics of SBI symposium)
40. Cost to conduct screening, brief intervention, and referral to treatment (SBIRT) in healthcare settings
41. A time-in-motion study of screening, brief intervention, and referral to treatment (SBIRT) implementation in healthcare settings
42. Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
43. Tracking the Quality of Addiction Treatment Over Time and Across States: Using the Federal Government’s “Signs” of Higher Quality
44. The mental health consequences of nonmedical prescription drug use among adolescents.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.